Sector revisions Genmab A/S Nasdaq

Stocks

GMAB

US3723032062

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 23:35:33 24/09/2026 HKT			5-day change	1st Jan Change
34.38 ^USD	-1.05%		-0.09%	+12.03%

07:57pm	AbbVie Says Health Canada Issues Notice of Compliance for EPKINLY in Follicular Lymphoma	MT
01:07pm	Hansa Biopharma brings in two new board members	FW

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	WUXI APPTEC CO., LTD.							18
	ARGENX SE							15
	INSMED INCORPORATED							22
	BIONTECH SE							20
	GENMAB A/S							16
	PHARMAESSENTIA CORPORATION							8
	EXELIXIS, INC.							16
	SUMMIT THERAPEUTICS INC.							13
	MADRIGAL PHARMACEUTICALS, INC.							17
	ARROWHEAD PHARMACEUTICALS, INC.							12
	IMMUNITYBIO, INC.							4
	CYTOKINETICS, INCORPORATED							20
	VAXCYTE, INC.							9
	BELITE BIO, INC							9
	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.						-	-
	BIOCON LIMITED							19
	SCHOLAR ROCK HOLDING CORPORATION							16
	Average							15
	Weighted average by Cap.							16

Bio Therapeutic Drugs

As early as today, start finding the best investment opportunities!